Covid-19 coronavirus: Possible safety issue spurs pause of antibody study

Independent monitors have paused enrollment in a study testing the Covid-19 antiviral drug remdesivir plus an experimental antibody therapy being developed by Eli Lilly that's similar to a treatment United States President Donald...